- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ALK-Abello B (ALKb)
ALK-Abello B stock price live, this page displays CSE ALKb stock exchange data. View the ALKb premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the ALK-Abello B real time stock price chart below.
What Is the ALK-Abello B Stock Price Today?
The ALK-Abello B stock price today is 220.40.
What Is the Stock Symbol for ALK-Abello B?
The stock symbol for ALK-Abello B is "ALKb."
What Stock Exchange Does ALK-Abello B Trade On?
ALK-Abello B is listed and trades on the Copenhagen stock exchange.
Is ALK-Abello B a Good Stock to Buy?
Determining whether ALK-Abello B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALKb quote. (ISIN: DK0061802139)
What Is the ALK-Abello B Stock Price Today?
The ALK-Abello B stock price today is 220.40.
What Is the Stock Symbol for ALK-Abello B?
The stock symbol for ALK-Abello B is "ALKb."
What Stock Exchange Does ALK-Abello B Trade On?
ALK-Abello B is listed and trades on the Copenhagen stock exchange.
Is ALK-Abello B a Good Stock to Buy?
Determining whether ALK-Abello B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALKb quote. (ISIN: DK0061802139)
220.40
+10.40(+4.95%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
210.60
221.00
52 wk Range
130.70
237.60
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
210.60221.00
52 wk Range
130.70237.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.73%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.73%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALKb Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
255.00
Upside
+15.70%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
ALK-Abello B Company Profile
ALK-Abelló A/S, an allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally. The company offers allergy immunotherapy products in the form of vaccines, injections, sublingual drops, and tablets for the treatment of various allergies, including grass and tree pollen, house dust mites, ragweed, Japanese cedar, peanuts, and tree nuts; adrenaline nasal sprays for emergency treatment of anaphylaxis and acute flares in chronic spontaneous urticaria; and ALK 014, a biologic for food allergies. It also provides GRAZAX/GRASTEK, a tablet for grass pollen allergy; ACARIZAX, ODACTRA, and MITICURE/SENSIMUNE, which are tablets for house dust mite allergies; ITULAZAX/ITULATEK, a tablet for tree pollen allergy; RAGWITEK/RAGWIZAX, a tablet for ragweed pollen allergy; and CEDARCURE, a tablet for Japanese cedar pollen allergy. In addition, the company offers consumer healthcare solutions, such as klarify.me, a digital patient engagement platform to help people manage their allergies. Further, it provides allergen extracts for use in the diagnosis of specific allergies, such as skin prick and blood test; and emergency medicine treatment, such as adrenaline autoinjectors, an intra-muscular injection of adrenaline for the treatment of acute life-threatening allergic reactions, including anaphylaxis. The company has a collaboration with Torii Pharmaceutical Co., Ltd. for the development of GRAZAX and CEDARCURE; and Dr. Reddy’s Laboratories for the development of Sensimune. ALK-Abelló A/S was founded in 1923 and is headquartered in Horsholm, Denmark.
Compare ALKb to Peers and Sector
Metrics to compare | ALKb | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALKbPeersSector | |
|---|---|---|---|---|
P/E Ratio | 40.8x | 23.3x | −0.6x | |
PEG Ratio | 0.87 | −0.14 | 0.00 | |
Price/Book | 7.6x | 4.3x | 2.6x | |
Price / LTM Sales | 7.7x | 2.9x | 3.3x | |
Upside (Analyst Target) | 15.7% | 22.7% | 44.8% | |
Fair Value Upside | Unlock | 15.9% | 5.5% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 255.00
(+15.70% Upside)
Earnings
Latest Release
Feb 20, 2026
EPS / Forecast
1.20 / 1.60
Revenue / Forecast
1.73B / 1.71B
People Also Watch
FAQ
What Is the ALK-Abello B (ALKb) Stock Price Today?
The ALK-Abello B stock price today is 220.40 DKK.
What Stock Exchange Does ALK-Abello B Trade On?
ALK-Abello B is listed and trades on the Copenhagen Stock Exchange.
What Is the Stock Symbol for ALK-Abello B?
The stock symbol for ALK-Abello B is "ALKb."
Does ALK-Abello B Pay Dividends? What’s The Current Dividend Yield?
The ALK-Abello B dividend yield is 0.73%.
What Is the ALK-Abello B Market Cap?
As of today, ALK-Abello B market cap is 48.83B DKK.
What Is ALK-Abello B's Earnings Per Share (TTM)?
The ALK-Abello B EPS (TTM) is 5.40.
When Is the Next ALK-Abello B Earnings Date?
ALK-Abello B will release its next earnings report on May 05, 2026.
From a Technical Analysis Perspective, Is ALKb a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has ALK-Abello B Stock Split?
ALK-Abello B has split 1 times.
How Many Employees Does ALK-Abello B Have?
ALK-Abello B has 2613 employees.
What is the current trading status of ALK-Abello B (ALKb)?
As of Feb 28, 2026, ALK-Abello B (ALKb) is trading at a price of 220.40 DKK, with a previous close of 210.00 DKK. The stock has fluctuated within a day range of 210.60 DKK to 221.00 DKK, while its 52-week range spans from 130.70 DKK to 237.60 DKK.
What Is ALK-Abello B (ALKb) Price Target According to Analysts?
The average 12-month price target for ALK-Abello B is 255.00 DKK, with a high estimate of 255 DKK and a low estimate of 255 DKK. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +15.70% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.